Bristol Myers Squibb (BMY)

[Johnny_C]

PFE is mentioned, so is Roche and GILD. I think it would be hard to get shareholder approval for less than the high of last year, assuming someone makes an offer.

Why would they even want to be bought out. Mass layoffs and restructuring follow. Analysts consensus on price targets do not mean anything in a M&A. BMY has a drug partnership with PFE. That drug and many others will be in further tests for years looking for new spouts to grow.

The only people that know what a buyout price for any company will be are the top management of the acquirer. What an analyst thinks is nonsense as the Pharma people make the decisions regarding forecasting future value, synergies ect.

In any event, not many companies can swallow BMY current market cap, putting a premium on today's PPS only swells a huge current market cap.

10% short term upside would be fine with me!